Advertisement

Topics

Biosys Technologies P Limited Company Profile

10:50 EDT 23rd September 2017 | BioPortfolio

THE COMPANY

· Established in the year 2001.

· Corporate Office at Bangalore.

· Branches at Chennai & Mangalore.

· Associate Overseas Offices in USA & Singapore.

· Lead by a Team of Technocrats.

· Supported by over 100 Trained Professionals.

· Association with Leaders in Respective Fields.







THE PHILOSOPY



· Adopt a Systematic Approach.

· Provide Standard-based solution.

· Enable State-of-art implementation.

· Future-proof solutions.

· Support Existing Technologies.

· Migration Path to Emerging Technologies.

· Adapt to Client Requirements.

· Provide Quality Support Services.

· Ensure minimum downtime.

· Provide Investment Protection.



THE ACTIVITIES



· R&D in the field of Bioinformatics

· Software Development

· Training in the field of Bioinformatics

· Communication Systems

· Call Center Solutions













THE PEOPLE



· Director Overseas-Dr .M. Sanjay Kanth

- M.B.B.S, M.P.H.

- Graduate from Bangalore University.

- Gold medallist in academics.

- Innovative and Service oriented.

- Innovative Technical Expertise in Special Projects.



· C.E.O- Mr. M. Sujay Kanth

- Mechanical Engineer by Profession and MBA.

- Specialized in Network Management.

- Six years of project management experience.





· M.D – Mr. Alluri Himavardhana Naidu

- Automobile Engineer from Karnataka University, Dharwad

- M.B.A

- Worked as a Senior Managerial positions, as Manager, Engineer, Maintenance Engineer, for 10 yrs in K.S.R.T.C.

- Member in Indian Institute of Road Transport.

- Member and Vice President of Indian Institute of Automobile Engineers, Hubli.









ADVISORY COMMITTEE



· Dr. S. Parameswaram. Ph. D Power controls

Director (Retd), C.P.R.I.

- 30 years experience in field of Engineering and Research



· Dr. .H .S. Anantha Padmanabha PhD Life sciences

- 35 years of experience in the field of Sandalwood tissue culture, Bio diversity culture.









· Dr. V Srikrishna MSC, MBA

- PhD Botany, PhD Environmental Sciences.

- 20 years of experience in Aquaculture

-

Location

Annapoorneswari Towers, # 125/31 11th main 33rd Cross Jaynagar IV Block
Bangalore
Karnataka
560 011
India

Contact

Phone: 91-80-6557704 and 91-80-6559911
Fax: 91-80-6557704
Email: sujaykanth@biosysinc.org


News Articles [459 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

PubMed Articles [409 Associated PubMed Articles listed on BioPortfolio]

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [308 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1308 Associated Companies listed on BioPortfolio]

Jubilant Biosys Ltd

Jubilant Biosys Ltd. (JBL) (www.jubilantbiosys.com), a subsidiary of Jubilant Organosys Ltd., provides integrated drug discovery and development solutions to the global pharmaceutical industry. Ju...

Jubilant Organosys Ltd

Jubilant Biosys Ltd. is a subsidiary of Jubilant Organosys Ltd., which provides integrated drug discovery and development solutions to the global pharmaceutical industry. The 120,000 sq. ft. state...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Biosys Technologies P Limited" on BioPortfolio

We have published hundreds of Biosys Technologies P Limited news stories on BioPortfolio along with dozens of Biosys Technologies P Limited Clinical Trials and PubMed Articles about Biosys Technologies P Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biosys Technologies P Limited Companies in our database. You can also find out about relevant Biosys Technologies P Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record